BRIEF-Immunitybio Receives UAE Marketing Authorization For Anktiva In Bladder and Lung Cancer
Reuters2026/07/29 22:47July 29 (Reuters) - Immunitybio Inc IBRX.O:
IMMUNITYBIO RECEIVES UNITED ARAB EMIRATES (UAE) MARKETING AUTHORIZATION FOR ANKTIVA® ACROSS BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER FOR CIS AND PAPILLARY DISEASE AND METASTATIC NON-SMALL CELL LUNG CANCER
Source text: ID:nBw1Hg1Mwa
Further company coverage: IBRX.O
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Why Intel Stock Surged After Trump Promised $5,000 to Every American
EXCLUSIVE-Nvidia in talks to invest in Anthropic’s mega IPO, sources say
The Woman Fixing a Microsoft Mess With Brutal Honesty -- WSJ
Mining leads Canadian Prime Minister’s C$1T investor pitchbook
Crypto prices
More
